
Divalproex Tablets
Epilepsy, Bipolar Disorder
125 · 250 · 500mg
Divalproex 125mg, 250mg and 500mg prolonged-release tablets, used in the management of epilepsy and bipolar disorder. Sodium valproate with valproic acid.
Divalproex is found under well-known brand names such as Depakote and Epilim. It works by balancing specific chemical signals in the brain to support neurological function.

Epilepsy, Bipolar Disorder
125 · 250 · 500mg
Divalproex 125mg, 250mg and 500mg prolonged-release tablets, used in the management of epilepsy and bipolar disorder. Sodium valproate with valproic acid.
Divalproex is a mood-stabilising and anti-epileptic medication. It functions by increasing the concentration of gamma-aminobutyric acid (GABA), a chemical that reduces nerve activity in the brain. By moderating these signals, the medication manages symptoms related to seizure activity or mood fluctuations in various conditions.
Divalproex is indicated to address complex brain and mood-related symptoms in adults and adolescents. It serves as a core treatment for Epilepsy, specifically to assist in managing various seizure types. It is also used in the management of Bipolar Disorder, where it functions to stabilise mood patterns.
Patients comparing brands like Depakote and Epilim seek reliable and consistent delivery of the active compound. These products are manufactured to ensure stable release into the system over time. As part of the wider Neurology selection, administration options include the prolonged-release tablet.
Liver function or blood clotting disorders are relevant factors for this medication. Ongoing chronic illnesses should be reviewed alongside the decision to begin treatment to ensure the medication is appropriate for individual health requirements.
Some individuals may experience common effects such as drowsiness, dizziness, or gastrointestinal discomfort. These symptoms often settle as the physiology adjusts to the molecule, though persistent reactions require monitoring.
Divalproex can interact with other medications or supplements that affect the central nervous system. Combining these with current treatment regimens requires clinical oversight to avoid unpredictable results. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.